Log in to save to my catalogue

Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recur...

Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recur...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_69be40e2442942ef80b0c29d17ff6300

Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation

About this item

Full title

Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation

Publisher

England: BioMed Central Ltd

Journal title

BMC gastroenterology, 2010-07, Vol.10 (1), p.71-71, Article 71

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Hepatitis B immune globulins (HBIG) in combination with nucleos(t)ide analogues (NA) are effectively used for the prevention of hepatitis B virus (HBV) recurrence after liver transplantation (LT). However, associated treatment costs for HBIG are exceedingly high.
Fresh frozen plasma obtained from blood donors with high anti-HBs levels (hyperimmu...

Alternative Titles

Full title

Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_69be40e2442942ef80b0c29d17ff6300

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_69be40e2442942ef80b0c29d17ff6300

Other Identifiers

ISSN

1471-230X

E-ISSN

1471-230X

DOI

10.1186/1471-230X-10-71

How to access this item